The gastric acid blocker Vonoprazan fumarate will be studied by Dr. Reddy's with approval from the CDSCO Panel.

Published Date: 02 Jun 2023

New Delhi: The Central Drug Standard Control's Subject Expert Committee (SEC) is operating in accordance with the findings of the bioequivalence (BE) study report.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Remote monitoring can improve recovery from cancer surgery

2.

Intractable cancers may respond better to treatment when using new radiation and high-performance computing.

3.

A Win for AI in Cancer; 2025's Transformative Drugs; FDA Clarifies 'Underway' Trials

4.

Conditional EU Nod for Weekly Pill in Pediatric Glioma

5.

high response rate when using a bispecific antibody to treat R/R multiple myeloma.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot